Daxdilimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Daxdilimab Usage And Synthesis

Uses

Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research[1][2].

References

[1] Patel S, et al. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon. 2021 Feb;7(2):e06158. DOI:10.1016/j.heliyon.2021.e06158
[2] Retamozo S, et al. An update of targeted therapeutic options for primary Sj?gren syndrome: current status and future development. Expert Opin Pharmacother. 2021 Dec;22(17):2359-2371. DOI:10.1080/14656566.2021.1951224

Daxdilimab(2245966-28-1)Related Product Information

• Namilumab
• Pembrolizumab
• Pritumumab
• Blosozumab
• Research Grade Cantuzumab (DHD14203)
• Alacizumab Pegol
• ITOLIZUMAB (monoclonal antybody)
• Bimagrumab
• Olokizumab
• Ocrelizumab